Dr. Alan Hyun Y. Baik, MD

Dr. Baik practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Baik's NPI, 1841610482, was assigned on April 22, 2014. Dr. Baik graduated from University of California, San Francisco School of Medicine in 2014. Dr. Baik's California license number on file is A139577.

Dr. Baik's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Baik's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Baik to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baik practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Baik's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Baik is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Baik has a license on file in California.

Dmand AI lists atherosclerosis, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, circulation problems, congestive heart failure, coronary artery disease and heart attack among the conditions Dr. Baik treats.

CMS data shows 344 Medicare services from Dr. Baik across 7 procedure codes in 2024, for 137 Medicare patients. Medicare paid $30,296 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Baik in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baik's median patient age at 71, with 49% women.

In 2024, Dr. Baik wrote 686 Medicare Part D claims for 95 patients. 79% of them were for generic drugs. CMS names the drug for 559 of them, across 16 drugs with 11 or more claims each, at $471,746 in total drug cost. In 2023, CMS named 398 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Baik for performance year 2024, reported as part of a group. Dr. Baik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baik as offering telehealth.

Dmand AI links 14 papers to Dr. Baik, published from 2009 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Cardiotoxicity, Immune Checkpoint Inhibitors and Oxygen. Dr. Baik has published most often in Cardiooncology. Dr. Baik's most frequent co-authors are Javid J. Moslehi, MD, Mandar A. Aras and Aarti H. Asnani, MD.

CMS Open Payments shows 18 general payments to Dr. Baik from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 59% of the total. Abbott Laboratories paid the most, $1,414.

Dr. Baik graduated from University of California, San Francisco School of Medicine in 2014.

Dr. Baik is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.